Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000162822 | SCV000213305 | likely benign | Hereditary cancer-predisposing syndrome | 2016-10-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000206173 | SCV000260095 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-12-17 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000411363 | SCV000489585 | likely benign | Lynch syndrome 1 | 2016-10-26 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000162822 | SCV000903998 | likely benign | Hereditary cancer-predisposing syndrome | 2018-03-08 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000411363 | SCV004018316 | benign | Lynch syndrome 1 | 2023-03-20 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
All of Us Research Program, |
RCV003995223 | SCV004826283 | likely benign | Lynch syndrome | 2023-12-01 | criteria provided, single submitter | clinical testing |